Old Web
English
Sign In
Acemap
>
authorDetail
>
Miguel A. Sanz
Miguel A. Sanz
Instituto Politécnico Nacional
Myeloid leukemia
Biology
Pharmacology
Genetics
Meta-analysis
4
Papers
43
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Impact of NADPH oxidase functional polymorphisms in acute myeloid leukemia induction chemotherapy
2017
Pharmacogenomics Journal
Juan Eduardo Megías-Vericat
Pau Montesinos
María José Herrero
Federico Moscardó
Virginia Bosó
Luis Rojas
David Martínez-Cuadrón
Rebeca Rodríguez-Veiga
Luis Sendra
José Cervera
José Luis Poveda
Miguel A. Sanz
Salvador F. Aliño
Show All
Source
Cite
Save
Citations (12)
A systematic review and meta-analysis of the impact of WT1 polymorphism rs16754 in the effectiveness of standard chemotherapy in patients with acute myeloid leukemia
2016
Pharmacogenomics Journal
Juan Eduardo Megías-Vericat
María José Herrero
Luis Rojas
Pau Montesinos
Virginia Bosó
Federico Moscardó
David Martínez-Cuadrón
José Luis Poveda
Miguel A. Sanz
Salvador F. Aliño
Show All
Source
Cite
Save
Citations (6)
Positive impact of ABCB1 polymorphisms in overall survival and complete remission in acute myeloid leukemia: a systematic review and meta-analysis
2016
Pharmacogenomics Journal
Juan Eduardo Megías-Vericat
Luis Rojas
María José Herrero
Virginia Bosó
Pau Montesinos
Federico Moscardó
José Luis Poveda
Miguel A. Sanz
Salvador F. Aliño
Show All
Source
Cite
Save
Citations (10)
Influence of ABCB1 polymorphisms upon the effectiveness of standard treatment for acute myeloid leukemia: A systematic review and meta-analysis of observational studies
2015
Pharmacogenomics Journal
Juan Eduardo Megías-Vericat
Luis Rojas
María José Herrero
Virginia Bosó
Pau Montesinos
Federico Moscardó
José Luis Poveda
Miguel A. Sanz
Salvador F. Aliño
Show All
Source
Cite
Save
Citations (15)
1